{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:48:22Z","timestamp":1773089302572,"version":"3.50.1"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Selenocysteine insertion sequence-binding protein 2 (<jats:italic>SECISBP2<\/jats:italic>) is crucial for the biosynthesis of selenoproteins, including iodothyronine deiodinases, which play a vital role in thyroid hormone metabolism. Mutations in <jats:italic>SECISBP2<\/jats:italic> can disrupt thyroid function, leading to various clinical manifestations across multiple systems. We present the case of a 3-year-old Saudi female who was referred for genetic testing due to poor growth, developmental abnormalities, and notable facial dysmorphism. Laboratory tests indicated elevated FT4 levels, low T3 levels, and modestly elevated TSH values. Whole-exome sequencing revealed a homozygous pathogenic variant in the <jats:italic>SECISBP2<\/jats:italic> gene (c.358C&amp;gt;T; p.Arg120Ter), correlating with the laboratory findings and the patient's clinical presentation. Additional variants of uncertain significance (VUS) in the <jats:italic>ARCN1<\/jats:italic> and <jats:italic>DNA2<\/jats:italic> genes were also identified but were considered clinically insignificant due to inheritance patterns and the absence of corresponding phenotypes in heterozygous family members. Treatment with liothyronine (L-T3) led to significant clinical improvement in growth and energy levels over a two-year follow-up period. This case highlights the importance of identifying the specific biochemical profile associated with <jats:italic>SECISBP2<\/jats:italic> deficiency and advocates for the inclusion of <jats:italic>SECISBP2<\/jats:italic> in genetic testing panels for endocrine and neurodevelopmental disorders to prevent diagnostic delays. The therapeutic efficacy of liothyronine in such cases is further supported.<\/jats:p>","DOI":"10.3389\/fped.2025.1637116","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T05:26:49Z","timestamp":1755840409000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: A homozygous selenocysteine insertion sequence-binding protein 2 (SECISBP2) gene mutation in a pediatric patient"],"prefix":"10.3389","volume":"13","author":[{"given":"Lina","family":"Almohammadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lama","family":"Alsayel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Aljumaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad","family":"Alhuthil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afaf","family":"Alsagheir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1210\/clinem\/dgz169","article-title":"Clinical and molecular analysis in 2 families with novel compound heterozygous SBP2 (SECISBP2) mutations","volume":"105","author":"Fu","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1089\/thy.2018.0015","article-title":"A novel homozygous selenocysteine insertion sequence binding protein 2 (SECISBP2, SBP2) gene mutation in a turkish boy","volume":"28","author":"\u00c7atli","year":"2018","journal-title":"Thyroid"},{"key":"B3","doi-asserted-by":"publisher","first-page":"803024","DOI":"10.3389\/fendo.2021.803024","article-title":"Inherited disorders of thyroid hormone metabolism defect caused by the dysregulation of selenoprotein expression","volume":"12","author":"Lee","year":"2022","journal-title":"Front Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1089\/ars.2013.5358","article-title":"SECISBP2 is essential for embryonic development and enhances selenoprotein expression","volume":"21","author":"Seeher","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/ng1654","article-title":"Mutations in SECISBP2 result in abnormal thyroid hormone metabolism","volume":"37","author":"Dumitrescu","year":"2005","journal-title":"Nat Genet"},{"key":"B6","volume-title":"ClinVar; [VCV0001323572.3] NM_024077.5(SECISBP2):c.358C>T (p.Arg120Ter)","year":"2021"},{"key":"B7","first-page":"c2018","volume-title":"Variant NM_001655.5:c.1004A>G [Internet]","year":"2023"},{"key":"B8","first-page":"c2018","volume-title":"Variant NM_001080449.3:c.3084G>T [Internet]","year":"2023"},{"key":"B9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1089\/ars.2009.2892","article-title":"The syndrome of inherited partial SBP2 deficiency in humans","volume":"12","author":"Dumitrescu","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1172\/JCI43653","article-title":"Mutations in the selenocysteine insertion sequence\u2013binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans","volume":"120","author":"Schoenmakers","year":"2010","journal-title":"J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1530\/EJE-11-0812","article-title":"Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation","volume":"166","author":"Hamajima","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1210\/jc.2009-2611","article-title":"Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene","volume":"95","author":"Azevedo","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"101280","DOI":"10.1016\/j.gim.2024.101280","article-title":"Severe neurodevelopmental phenotype, diagnostic, and treatment challenges in patients with SECISBP2 deficiency","volume":"26","author":"Stoupa","year":"2024","journal-title":"Genet Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1210\/jc.2009-0686","article-title":"Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X)","volume":"94","author":"Di Cosmo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajhg.2016.06.011","article-title":"ARCN1 mutations cause a recognizable craniofacial syndrome due to COPI-mediated transport defects","volume":"99","author":"Izumi","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ajhg.2012.12.014","article-title":"Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability","volume":"92","author":"Ronchi","year":"2013","journal-title":"Am J Hum Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41420-024-02029-9","article-title":"A novel mutation of DNA2 regulates neuronal cell membrane potential and epileptogenesis","volume":"10","author":"Liu","year":"2024","journal-title":"Cell Death Discov"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1637116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T05:26:50Z","timestamp":1755840410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1637116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":17,"alternative-id":["10.3389\/fped.2025.1637116"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1637116","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"article-number":"1637116"}}